- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00252616
Timing of Target Enteral Feeding in the Mechanically Ventilated Patient
December 16, 2013 updated by: Todd Rice, Vanderbilt University
Phase III Study of Early vs. Delayed Goal Enteral Nutrition in Mechanically Ventilated Patients
This study tests the hypothesis that initial trophic enteral feedings will increase the time alive and free of mechanical ventilation as compared to initial goal enteral feedings in patients who are mechanically ventilated.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Mechanically ventilated patients, within 48 hours of initiating mechanical ventilation, are randomized in a 1:1 fashion to receive trophic enteral feedings for 96 hours followed by advancement to goal feeding rates or initial advancement to goal feeding rates.
Primary endpoints are ventilator free days, ICU-free days, gastrointestinal intolerances, development of nosocomial infections, and mortality.
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria: Patients will be eligible for inclusion in the study if they meet the following criteria:
- Mechanical ventilation expected to last at least 72 hours.
- Presence of, or primary physician's intent to place, an enteral feeding tube and begin enteral feeds.
Exclusion Criteria:
- More than 48 hours elapsed since both inclusion criteria met.
- Patient, legal representative, or physician refuses consent or is unavailable to provide consent.
- Patient, legal representative, or physician not committed to full support (Exception: A patient will not be excluded if he/she would receive all supportive care except for attempts at resuscitation from cardiac arrest).
- Presence of malignant or irreversible condition and estimated 28 day mortality greater than 50%.
- Severe or refractory shock.
- Moribund patients not expected to survive 24 hours from start of enteral feeding (as determined by primary medical team).
- Child-Pugh score greater than 10.
- Presence of partial or complete mechanical bowel obstruction, or ischemia, or infarction.
- Current TPN use or intent to use TPN within 7 days.
- Severe malnutrition with BMI less than 18.5 and/or loss of more than 30% total body weight in the previous 6 months.
- Neuromuscular disease impairing the ability to ventilate spontaneously.
- Laparotomy expected within 7 days.
- Unable to raise head of bed 45°.
- greater than 30% total body surface area burns.
- Absence of GI tract/short bowel syndrome - defined as entire length of small bowel totaling 4 feet or less.
- Presence of high-output (> 500 cc/day) enterocutaneous fistula.
- Age less than 13 years
- Allergy to enteral formula
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
trophic feeds
|
10cc/hr
|
|
Active Comparator: 2
Full-calorie feeds
|
10cc/hr
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Ventilator-free days
Time Frame: day 28
|
day 28
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mortality
Time Frame: 28 days
|
28 days
|
|
ICU-free days
Time Frame: day 28
|
day 28
|
|
Incidence of Gastrointestinal intolerances
Time Frame: day 14
|
day 14
|
|
Organ failure-free days
Time Frame: day 28
|
day 28
|
|
Changes in inflammation as measured by serum cytokine levels
Time Frame: baseline vs. days 6 and 12
|
baseline vs. days 6 and 12
|
|
Changes in levels of nutrition as measured by serum albumin, total protein, and pre-albumin
Time Frame: baseline vs. days 6 or 12
|
baseline vs. days 6 or 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Todd W Rice, MD, MSc, Vanderbilt University School of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2003
Primary Completion (Actual)
October 1, 2009
Study Completion (Actual)
October 1, 2009
Study Registration Dates
First Submitted
November 9, 2005
First Submitted That Met QC Criteria
November 10, 2005
First Posted (Estimate)
November 11, 2005
Study Record Updates
Last Update Posted (Estimate)
December 17, 2013
Last Update Submitted That Met QC Criteria
December 16, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 020744
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.